Skip to Content
Toggle navigation
image/svg+xml
Switch language
Switch language
Deutsch
English
Español
Français
Italiano
Português do Brasil
中文
Login
Search Constraints
Start Over
Filtering by:
Committee
Gregory Lesinski, Emory University
Remove constraint Committee: Gregory Lesinski, Emory University
1
-
7
of
7
Sort by relevance
relevance
date uploaded ▼
date uploaded ▲
date modified ▼
date modified ▲
Number of results to display per page
10 per page
10
per page
20
per page
50
per page
100
per page
View results as:
List
Gallery
Masonry
Slideshow
Search Results
MERTK inhibition selectively activates a DC – T-cell axis to provide anti-leukemia imm...
Immunologic Mechanisms of Colorectal Liver Metastases: Potential for Novel Therapies
MEK inhibition mediates immunomodulatory factors and cell populations in advanced bili...
Enhancing Oncolytic Reovirus with Doxorubicin for Triple-Negative Breast Cancer Therapy
Investigating the Roles of ACLY in Multiple Myeloma Biology and Drug Sensitivity
PDGFB Is A Potent Inflammatory Driver In Pediatric High-Grade Glioma
Reprogramming the Immune Phenotype of Rb-deficient Prostate Cancer Cells via BET Inhib...
Toggle facets
Limit your search
Year
Fall 2019
1
Fall 2022
1
Fall 2023
1
Spring 2019
1
Spring 2020
1
more
Years
»
School
Laney Graduate School
6
Emory College
1
Department
Biological and Biomedical Sciences
5
Biology
1
Clinical Research
1
Degree
Ph.D.
4
M.S.
2
B.S.
1
Submission Type
Dissertation
4
Master's Thesis
2
Honors Thesis
1
Research Field
Biology, Cell
6
Health Sciences, Oncology
3
Biology, General
2
Health Sciences, Immunology
2
Biology, Genetics
1
more
Research Fields
»
Committee
Gregory Lesinski, Emory University
[remove]
7
Amita Manatunga, Emory University
1
Bernardo Mainou, Emory University
1
Brian Olson, Emory University
1
Brian Robinson, Emory University
1
more
Committees
»
Keyword
ACLY
1
Acute Leukemia
1
BET
1
CD8 T cells
1
Cancer Immunology
1
more
Keywords
»